These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12556214)

  • 21. Antiparasitic therapy in children.
    Moon TD; Oberhelman RA
    Pediatr Clin North Am; 2005 Jun; 52(3):917-48, viii. PubMed ID: 15925668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruthenium Metallotherapeutics: Novel Approaches to Combatting Parasitic Infections.
    Britten NS; Butler JA
    Curr Med Chem; 2022 Aug; 29(31):5159-5178. PubMed ID: 35366762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles for antiparasitic drug delivery.
    Sun Y; Chen D; Pan Y; Qu W; Hao H; Wang X; Liu Z; Xie S
    Drug Deliv; 2019 Dec; 26(1):1206-1221. PubMed ID: 31746243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical appraisal of microemulsions for drug delivery: part II.
    Sapra B; Thatai P; Bhandari S; Sood J; Jindal M; Tiwary AK
    Ther Deliv; 2014 Jan; 5(1):83-94. PubMed ID: 24341819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-parasitic Antibodies from Phage Display.
    Goulart LR; da S Ribeiro V; Costa-Cruz JM
    Adv Exp Med Biol; 2017; 1053():155-171. PubMed ID: 29549639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiparasitic drugs. Review of the useful drugs in the treatment of classic and emergent parasitic diseases].
    Pérez JL; Carranza C; Mateos F
    Rev Esp Quimioter; 2009 Jun; 22(2):93-105. PubMed ID: 19544101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-implanted tiny needles as alternative to traditional parenteral administrations for controlled transdermal drug delivery.
    Chen BZ; Yang Y; Wang BB; Ashfaq M; Guo XD
    Int J Pharm; 2019 Feb; 556():338-348. PubMed ID: 30553955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinases as targets for antiparasitic chemotherapy drugs.
    Canduri F; Perez PC; Caceres RA; de Azevedo WF
    Curr Drug Targets; 2007 Mar; 8(3):389-98. PubMed ID: 17348832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections.
    Edwards G; Krishna S
    Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):233-42. PubMed ID: 15029513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming challenges in the diagnosis and treatment of parasitic infectious diseases in migrants.
    Norman FF; Comeche B; Chamorro S; López-Vélez R
    Expert Rev Anti Infect Ther; 2020 Feb; 18(2):127-143. PubMed ID: 31914335
    [No Abstract]   [Full Text] [Related]  

  • 31. Parasite Cathepsin D-Like Peptidases and Their Relevance as Therapeutic Targets.
    Sojka D; Hartmann D; Bartošová-Sojková P; Dvořák J
    Trends Parasitol; 2016 Sep; 32(9):708-723. PubMed ID: 27344362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microemuslsions in advanced drug delivery.
    Sharma AK; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1177-85. PubMed ID: 25711493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The approaches of the Russian school of parasitologists and immunologists to the therapy of parasitic diseases].
    Ozeretskovskaia NN
    Med Parazitol (Mosk); 1998; (2):12-5. PubMed ID: 9691613
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious disease and the extreme sport athlete.
    Young CC; Niedfeldt MW; Gottschlich LM; Peterson CS; Gammons MR
    Clin Sports Med; 2007 Jul; 26(3):473-87. PubMed ID: 17826196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs.
    Rohmer M; Grosdemange-Billiard C; Seemann M; Tritsch D
    Curr Opin Investig Drugs; 2004 Feb; 5(2):154-62. PubMed ID: 15043389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colloidal soft matter as drug delivery system.
    Bonacucina G; Cespi M; Misici-Falzi M; Palmieri GF
    J Pharm Sci; 2009 Jan; 98(1):1-42. PubMed ID: 18452176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery system of anti-fungal and parasitic agents.
    Maesaki S
    Curr Pharm Des; 2002; 8(6):433-40. PubMed ID: 12069380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.